- Pharma
- 1 min read
Merck to supply up to 1 mln courses of COVID-19 pill to Canada
The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.- Published On Dec 4, 2021 at 12:01 PM IST

The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)
- Published On Dec 4, 2021 at 12:01 PM IST
- See more on:
- canada,
- merck,
- canada merck & co,
- covid 19,
- health canada,
- health news
Join the community of 2M+ industry professionals.
Subscribe to Newsletter to get latest insights & analysis in your inbox.
All about ETHealthworld industry right on your smartphone!
- Download the ETHealthworld App and get the Realtime updates and Save your favourite articles.

Comments
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions